刺痛癌症:发展,临床应用和刺激动剂的向性输送
Yannick Gabriel Nerdinger1,2,3,4,5, Amanda Katharina Binder1,2,3,4,5, Franziska Bremm1,2,3,4,5
1Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
新型STING激动剂通过调节瘤微环境和免疫细胞来显示癌症免疫治疗的前景. 纳米技术提高了它们的交付和有效性,解决了当前临床试验的局限性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 纳米技术 纳米技术
背景情况:
- 癌症发病率上升和传统治疗效果有限,需要新的治疗方法.
- 检查点抑制剂和CAR-T细胞等免疫疗法已经推进了癌症治疗,但反应率各不相同.
- STING (Stimulator of Interferon Genes) 激动剂是新兴的免疫调节剂,其向瘤微环境.
研究的目的:
- 审查在癌症治疗临床试验中评估的STING激动剂.
- 讨论STING激动剂对瘤透免疫细胞,特别是巨细胞的影响.
- 探索新兴的临床前STING激动剂候选人和纳米技术战略,以提高疗效.
主要方法:
- 对精选的STING激动剂进行临床试验数据的审查.
- 对STING激动剂对细胞因子概况和免疫细胞功能在瘤微环境中的作用的分析.
- 对新型STING激动剂和基于纳米技术的输送系统进行临床前研究的调查.
主要成果:
- 在临床前模型中,STING激动剂显示出潜力,但临床翻译面临挑战.
- 激活STING通路可以改变瘤微环境并重塑免疫细胞功能.
- 纳米技术提供了一种提高STING激剂强度,生物分布和持续TME积累的策略.
结论:
- 刺痛激动剂代表了癌症免疫治疗的有希望的途径,正在进行优化和临床评估.
- 了解STING激动剂与瘤透免疫细胞,特别是巨细胞的相互作用至关重要.
- 使用纳米技术的组合方法是提高STING激动剂治疗疗效的关键.
更多相关视频
05:22Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice
Published on: February 24, 2023
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
